Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Bioabsorbable Stents Market, by Biomaterial
1.4.2 North America Bioabsorbable Stents Market, by Application
1.4.3 North America Bioabsorbable Stents Market, by End User
1.4.4 North America Bioabsorbable Stents Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Bioabsorbable Stents Market by Biomaterial
3.1 North America Polymeric Market by Country
3.2 North America Metallic Market by Country
Chapter 4. North America Bioabsorbable Stents Market by Application
4.1 North America Coronary Artery Disease Market by Country
4.2 North America Peripheral Artery Disease Market by Country
Chapter 5. North America Bioabsorbable Stents Market by End User
5.1 North America Hospital Market by Country
5.2 North America Cardiac Center Market by Country
Chapter 6. North America Bioabsorbable Stents Market by Country
6.1 US Bioabsorbable Stents Market
6.1.1 US Bioabsorbable Stents Market by Biomaterial
6.1.2 US Bioabsorbable Stents Market by Application
6.1.3 US Bioabsorbable Stents Market by End User
6.2 Canada Bioabsorbable Stents Market
6.2.1 Canada Bioabsorbable Stents Market by Biomaterial
6.2.2 Canada Bioabsorbable Stents Market by Application
6.2.3 Canada Bioabsorbable Stents Market by End User
6.3 Mexico Bioabsorbable Stents Market
6.3.1 Mexico Bioabsorbable Stents Market by Biomaterial
6.3.2 Mexico Bioabsorbable Stents Market by Application
6.3.3 Mexico Bioabsorbable Stents Market by End User
6.4 Rest of North America Bioabsorbable Stents Market
6.4.1 Rest of North America Bioabsorbable Stents Market by Biomaterial
6.4.2 Rest of North America Bioabsorbable Stents Market by Application
6.4.3 Rest of North America Bioabsorbable Stents Market by End User
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Approvals & Trials:
7.1.5.2 Acquisition and Mergers:
7.2 B. Braun Melsungen AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.3 BIOTRONIK SE & Co. KG
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Approvals & Trials:
7.4 Boston Scientific Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 MicroPort Scientific Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 Terumo Corporation
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental Analysis
7.7 Arterius Ltd.
7.7.1 Company Overview
7.7.2 Recent strategies and developments:
7.7.2.1 Partnerships, Collaborations, and Agreements:
7.8 Elixir Medical Corporation
7.8.1 Company Overview
7.9 Amaranth Medical, Inc.
7.9.1 Company Overview
7.10. REVA Medical, Inc.
7.10.1 Company Overview
Unique Offerings 